Well, it just went up to $524 million!
AstraZeneca faces costs of up to $1.2bn from the escalating number of legal cases brought by patients and regulators suing it over alleged improper marketing and side effects caused by Seroquel , its blockbuster antipsychotic drug that generated $4.9bn in sales last year.
In its fourth quarter, the group boosted provisions to $524m for a settlement with the US Attorney's Office investigation into sales and marketing practices of Seroquel.More from Andrew Jack at the FT
No comments:
Post a Comment